Parkinsons Disease

Clinical Trial Title A Phase 2/3, Double-Blind, Placebo-Controlled Study of BHV-8000 in Participants with Early Parkinson’s Disease
Trial Status Open to Enrollment
Start Date 09/09/2025
Location Legacy Medical Group-Neurology at Good Samaritan
Trial Type Parkinson's Disease
Specific Condition Parkinson's Disease
Description

A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease.
Eligibility Criteria

Eligibility Criteria

  • Male or female participants 40 to 85 years of age, inclusive, at the time of informed consent.
  • Meet the diagnostic criteria for "Probable PD" as assessed on the Movement Disorder Society (MDS) Clinical Diagnostic Criteria for PD as assessed by the Investigator.
  • Have a clinician-documented diagnosis of idiopathic PD with an onset within 2 years of the Screening Visit
IRB Number 10913
Notes A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Principal Investigator Jill Baird, MD
Contact Name Madeline Cooke
Contact Phone 503-413-7094
Contact Fax 503-413-6861
Contact E-Mail macooke@lhs.org